TipRanks on MSN
Crispr Therapeutics rumor highlighted in Betaville blog
A rumor regarding Crispr Therapeutics (CRSP) was highlighted in Ben Harrington’s M&A-focused Betaville blog, contacts tell The Fly. Shares of ...
Pharmaceutical Technology on MSN
Potentially “groundbreaking” FDA gene therapy pathway leaves key issues unresolved
A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.
Absolutely! Please provide the article for which you'd like an SEO-friendly meta description, and I'll generate one based on your input.
As of November 27, CRISPR Therapeutics AG (NASDAQ:CRSP) has a moderately positive opinion, with 60% analysts covering it having a Buy or equivalent rating. With a consensus 1-year median price target ...
This year has seen the approval of several first-in-class therapies for HAE, but in a fragmented space, experts question ...
To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
19h
Lyme disease often goes undetected when it's most treatable. These teens are working to change that.
Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...
To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
Scientists developed wheat that helps create its own natural fertilizer, promising cleaner and more affordable farming.
But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...
Following the weekend data presentation, Citizens voiced optimism regarding CRISPR’s in-vivo projects. The firm noted some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback